Nevro Corp. Stock
Your prediction
Pros and Cons of Nevro Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nevro Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nevro Corp. | - | - | - | - | - | - | - |
| SI-BONE Inc | 0.000% | -4.202% | 0.885% | -9.524% | -32.544% | - | - |
| Lantheus Holdings Inc | 1.130% | 0.842% | 12.239% | -19.485% | 25.699% | -12.933% | - |
| Lemaitre Vascular Inc | 0.520% | -0.513% | 0.000% | 22.785% | 37.589% | - | - |
Comments
Nevro Corp. (NYSE: NVRO) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $5.85 price target on the stock, down previously from $6.00.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $4.00 price target on the stock, down previously from $9.00.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Piper Sandler from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for NVRO provided by MarketBeat